Medical science liaison

TRINET PHARMA RELAUNCHES LIFE SCIENCES RECRUITING SERVICES UNDER NEW LEADERSHIP

Retrieved on: 
Thursday, February 16, 2023

DALLAS, Feb. 16, 2023 /PRNewswire/ -- TriNet Pharma, a high-performing recruiting and talent consulting agency specializing in the Medical Science Liaison (MSL) space, is restructuring its senior management team with new leadership that provides diverse experience and pays tribute to the trailblazing spirit of their late founder and CEO Bryan Vaughan. After Vaughn's passing, principal investor and co-founder Terry Mulloy became CEO and now Mara Vaughan, who also founded the company with her late husband, will be joining the leadership team as President. Since its founding in 2009, TriNet Pharma has been a leader in talent consulting and recruiting services for life sciences companies worldwide. To continue that level of service for their clients, Terry and Mara have brought in industry recruiting veteran Elaine Peng as Senior Vice President to lead the company's innovative and proprietary recruitment solutions.

Key Points: 
  • Since its founding in 2009, TriNet Pharma has been a leader in talent consulting and recruiting services for life sciences companies worldwide.
  • In addition to the strategically renovated leadership team, TriNet Pharma is recognizing Founder, Bryan Vaughan, for his valiant efforts in the industry, through a legacy grant in his name.
  • "TriNet Pharma is rooted in its mission and values and will consistently work to pay tribute to the legacy that Bryan spent his life achieving."
  • TriNet Pharma is an outcome-based agency with a refined set of pre-marketing strategies for clients, which is a competitive differentiator that sets them apart from other life science recruiting agencies.

Alucio™ Expands Senior Team with Experienced Healthcare Technology Leader

Retrieved on: 
Monday, February 6, 2023

SAN FRANCISCO, Feb. 6, 2023 /PRNewswire-PRWeb/ -- Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, is pleased to announce that Melissa Chun has joined the company's senior team as its Vice President of Strategic Engagement.

Key Points: 
  • She will also help support the ongoing development of key life science industry partnerships for the company.
  • Beacon is a user-centered, cloud-based scientific exchange platform specifically designed for Medical Science Liaisons (MSLs), Medical Affairs professionals and Market Access teams.
  • With more than a decade working in the healthcare and technology arenas, Melissa brings a unique skill set, strong industry relationships and highly relevant experience to Alucio.
  • Her prior roles include senior positions within business development, customer engagement, and scientific development, including with companies directly serving life science customers.

Alucio™ Receives Well Respected ISO 27001 Certification

Retrieved on: 
Monday, January 23, 2023

SAN FRANCISCO, Jan. 23, 2023 /PRNewswire-PRWeb/ -- Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, today announced it has received formal ISO 27001 certification. ISO 27001 (International Organization of Standardizations) is an internationally recognized and uniquely auditable standard that deals with the overall management of information security.

Key Points: 
  • ISO 27001 (International Organization of Standardizations) is an internationally recognized and uniquely auditable standard that deals with the overall management of information security.
  • The recent ISO 27001 certification, by an accredited certification body, affirms the diligent approach the company has taken in this area.
  • In addition to Alucio being ISO 27001 certified, its flagship product, Beacon, is also GDPR compliant.
  • "We are pleased to obtain this latest stamp of approval through the well-regarded ISO 27001 certification process, which is a major milestone in our company journey."

Tom Caravela Launches a Podcast for Medical Science Liaisons

Retrieved on: 
Friday, December 9, 2022

Tom Caravela introduces the MSL Talk podcast for Medical Science Liaisons (MSLs) and Medical Affairs professionals.

Key Points: 
  • As an expert in the Medical Affairs and Medical Science Liaison community, Tom decided to launch a podcast called MSL Talk.
  • Providing resourceful tips and best practices for MSLs, Medical Affairs professionals, and those seeking jobs in the pharmaceutical industry can truly benefit from this podcast.
  • Tom Caravela hosts unscripted podcasts and invites notable Medical Affairs Leaders and MSL professionals to the platform for relevant discussions.
  • With a staff of recruiters that have 55 years of combined experience, The Carolan Group has emerged as a leading Medical Affairs and Medical Science Liaison Executive Search Firm.

Alucio™ Releases Updated Presentation Builder Feature for its Beacon Platform

Retrieved on: 
Thursday, December 1, 2022

SAN FRANCISCO, Calif., Dec.1, 2022 /PRNewswire-PRWeb/ -- Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, today announced updates to its unique presentation builder feature within its Beacon scientific exchange platform. These enhancements provide users with new content assembly options while ensuring pharma regulatory compliance. Beacon is a modern content activation and HCP engagement platform built specifically for Medical Science Liaisons (MSLs), Medical Affairs professionals, and Market Access teams.

Key Points: 
  • SAN FRANCISCO, Calif., Dec.1, 2022 /PRNewswire-PRWeb/ -- Alucio, a fast-growing provider of cloud-based software for the life sciences industry, today announced updates to its unique presentation builder feature within its Beacon scientific exchange platform.
  • Beacon is a modern content activation and HCP engagement platform built specifically for Medical Science Liaisons (MSLs), Medical Affairs professionals, and Market Access teams.
  • Beacon's presentation builder stands out by offering the most advanced and user-friendly content assembly capabilities in the marketplace today.
  • "Beacon's integrated presentation builder is a key platform feature that aligns with an important and growing trend toward personalization in the market.

Alucio™ Integrates AI Into Its Beacon Scientific Exchange Platform

Retrieved on: 
Monday, November 7, 2022

SAN FRANCISCO, November 07, 2022 /PRNewswire-PRWeb/ -- Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, today announced the integration of artificial intelligence (AI) and machine learning (ML) capabilities into Beacon to enhance the platform's search functionality. Beacon is a modern content activation and HCP engagement platform built specifically for Medical Science Liaisons (MSLs), Medical Affairs professionals and Market Access teams.

Key Points: 
  • Beacon is a modern content activation and HCP engagement platform built specifically for Medical Science Liaisons (MSLs), Medical Affairs professionals and Market Access teams.
  • This new update will provide users with a powerful and intelligent full-text search feature to find and locate various documents quickly on the platform.
  • This is especially important in life science companies that are managing a significant amount of complex medical and scientific content.
  • Alucio's flagship product, Beacon, is a modern, cloud-based scientific exchange platform that enhances scientific dialogue and engagement between life science companies and healthcare professionals.

KORU Medical Systems Appoints Brent Rutland as Vice President of Medical Affairs

Retrieved on: 
Wednesday, October 12, 2022

KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on the development of innovative and easy-to-use subcutaneous (SQ) infusion solutions, today announced the appointment of Brent Rutland as the Companys new Vice President of Medical Affairs.

Key Points: 
  • KORU Medical Systems, Inc. (NASDAQ: KRMD) (KORU Medical or the Company), a leading medical technology company focused on the development of innovative and easy-to-use subcutaneous (SQ) infusion solutions, today announced the appointment of Brent Rutland as the Companys new Vice President of Medical Affairs.
  • Most notably, Brent aided Baxter in the launch of Hylenex for SQ rehydration where he also helped build the Medical Affairs department.
  • I was immediately drawn to the opportunity to work at KORU Medical as I saw the potential for future growth supported by building out the medical science and the team, said Brent Rutland, Vice President of Medical Affairs.
  • Medical affairs helps fulfill the unmet needs of the patient through the generation and delivery of scientific evidence to various key outside stakeholders.

Alucio™ Releases Enhanced Analytics Module for its Beacon Scientific Exchange Platform

Retrieved on: 
Tuesday, September 6, 2022

SAN FRANCISCO, Sept. 6, 2022 /PRNewswire-PRWeb/ -- Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, today announced a new and improved reporting and analytics module within Beacon. This updated version allows for additional data and insights, and greater information accessibility to various business audiences, elevating strategic decision making within life science companies. Beacon is a modern content activation and HCP engagement platform built specifically for Medical Science Liaisons (MSLs), Medical Affairs professionals and Market Access teams.

Key Points: 
  • SAN FRANCISCO, Sept. 6, 2022 /PRNewswire-PRWeb/ -- Alucio, a fast-growing provider of cloud-based software for the life sciences industry, today announced a new and improved reporting and analytics module within Beacon.
  • Beacon is a modern content activation and HCP engagement platform built specifically for Medical Science Liaisons (MSLs), Medical Affairs professionals and Market Access teams.
  • More specifically, this new module provides detailed, session-based user activity analyses across multiple Beacon instances including virtual, desktop, and tablet.
  • Alucio's flagship product, Beacon, is a modern, cloud-based scientific exchange platform that enhances scientific dialogue and engagement between life science companies and healthcare professionals.

Prolacta Bioscience Appoints Dr. Erin Hamilton Spence as Director of Clinical Education and Professional Development

Retrieved on: 
Tuesday, August 2, 2022

DUARTE, Calif., Aug. 2, 2022 /PRNewswire/ -- Prolacta Bioscience ,the world's leading hospital provider of 100% human milk-based nutritional products for critically ill, premature infants, announced today that neonatologist and breastfeeding advocate Erin Hamilton Spence, MD, IBCLC, has been appointed director of clinical education and professional development.

Key Points: 
  • DUARTE, Calif., Aug. 2, 2022 /PRNewswire/ -- Prolacta Bioscience ,the world's leading hospital provider of 100% human milk-based nutritional products for critically ill, premature infants, announced today that neonatologist and breastfeeding advocate Erin Hamilton Spence, MD, IBCLC, has been appointed director of clinical education and professional development.
  • "Dr. Erin Hamilton Spence is an experienced neonatologist with a demonstrated history of clinical leadership in some of the country's top NICUs," said Melinda Elliott, MD, chief medical officer at Prolacta.
  • Hamilton Spence holds an academic appointment as a clinical assistant professor at Texas Christian University School of Medicine.
  • This position for Prolacta marries all my strongest interests in human milk nutrition research, education, and quality," Hamilton Spence said.

PharmaForce International: US Oncology Companies Shift Toward Tumor-Specific Sales Channel Alignments

Retrieved on: 
Thursday, June 2, 2022

To contend in the highly competitive atmosphere, these leading companies are constantly making changes to their commercial approaches.

Key Points: 
  • To contend in the highly competitive atmosphere, these leading companies are constantly making changes to their commercial approaches.
  • The report covers all of the key findings and major changes being made among the Oncology market.
  • One note-worthy finding, specifically, is the prevalent shift toward tumor-specific Sales channel alignments.
  • To better serve key customers, several of the profiled companies in the Oncology study have recently re-aligned their Sales sleeves to a tumor-centric model.